Most common health problems in general practice among adolescents, and young adults’ survivors of lymphoma: a register-based cohort study in Norway

References

• Barr RD, Ferrari A, Ries L, et al. Cancer in adolescents and young adults: a narrative review of the current status and a view of the future. JAMA Pediatr. 2016;170(5):495–501. doi: 10.1001/jamapediatrics.2015.4689.
   PubMed Web of Science ®Google Scholar
• NORDCAN. Age-Standardized Rate (Nordic) per 100 000, Incidence, Males and Females, age [15-39], in 2020. Norway. Website: https://nordcan.iarc.fr/en/dataviz/bars?cancers=370&sexes=1_2&populations=578&age_start=3&age_end=7&map_view_per=countries. Accessed March 2023.
   Google Scholar
• Årsrapport 2021 med resultater og forbedringstiltak fra Nasjonalt kvalitetsregister for lymfoide maligniteter. Oslo: Kreftregisteret, 2022.
   Google Scholar
• Mellblom AV, Kiserud CE, Rueegg CS, et al. Self-reported late effects and long-term follow-up care among 1889 long-term Norwegian childhood, adolescent, and young adult cancer survivors (the NOR-CAYACS study). Support Care Cancer. 2021;29(6):2947–2957. doi: 10.1007/s00520-020-05790-6.
   PubMed Web of Science ®Google Scholar
• Bhakta N, Liu Q, Ness KK, et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude lifetime cohort study (SJLIFE). Lancet. 2017;390(10112):2569–2582. doi: 10.1016/S0140-6736(17)31610-0.
   PubMed Web of Science ®Google Scholar
• Cairo MS, Beishuizen A. Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives. Br J Haematol. 2019;185(6):1021–1042. doi: 10.1111/bjh.15764.
   PubMed Web of Science ®Google Scholar
• Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. 2014;14(1):61–70. doi: 10.1038/nrc3634.
   PubMed Web of Science ®Google Scholar
• The Norwegian Directorate of Health. Norwegian national plan of action with guidelines for diagnostics, treatment, and follow-up of patients with malignant lymphomas. National guidelines. (In Norwegian). IS-3025. Oslo, December 2021.
   Google Scholar
• Khan NF, Watson E, Rose PW. Primary care consultation behaviours of long-term, adult survivors of cancer in the UK. Br J Gen Pract. 2011;61(584):197–199. doi: 10.3399/bjgp11X561195.
   PubMed Web of Science ®Google Scholar
• Thorsen B, Frydenberg K, Wensaas KA, et al. The role of general practitioners in cancer care. Tidsskr Nor Legeforen 2019. doi: 10.4045/tidsskr.19.0180.
   Google Scholar
• Kahn JM, Kelly KM. Adolescent and young adult Hodgkin lymphoma: raising the bar through collaborative science and multidisciplinary care. Pediatr Blood Cancer. 2018; 65(7):e27033.
   PubMed Web of Science ®Google Scholar
• Lie HC, Mellblom AV, Brekke M, et al. Experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood lymphoma. Support Care Cancer. 2017;25(8):2445–2454. doi: 10.1007/s00520-017-3651-6.
   PubMed Web of Science ®Google Scholar
• Helsedirektoratet. KUHR-databasen. (In Norwegian). Accessed March 2022. https://www.helsedirektoratet.no/tema/statistikk-registre-og-rapporter/helsedata-og-helseregistre/kuhr.
   Google Scholar
• Larsen IK, Småstuen M, Johannesen TB, et al. Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218–1231. doi: 10.1016/j.ejca.2008.10.037.
   PubMed Web of Science ®Google Scholar
• Pedersen AG, Ellingsen CL. Data quality in the causes of death registry. Tidsskr Nor Laegeforen. 2015;135(8):768–770. doi: 10.4045/tidsskr.14.1065.
   PubMedGoogle Scholar
• World Health Organization. International classification of diseases for oncology. Third edition. Geneva: WHO; 2000 Website: http://apps.who.int/iris/bitstream/10665/96612/1/9789241548496_eng.pdf. Accessed March 2022.
   Google Scholar
• Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019–5032. doi: 10.1182/blood-2011-01-293050.
   PubMed Web of Science ®Google Scholar
• WHO. International classification of primary care., Second edition (ICPC-2). Geneva: WHO; 2003.
   Google Scholar
• World Health Organization. International Classification of Primary Care. Second edition (ICPC-2). Accessed March 2022. Website: https://www.who.int/classifications/icd/adaptations/icpc2/en/.
   Google Scholar
• Helsedirektoratet. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av pasienter med maligne lymfomer. Nasjonale faglige retningslinjer (In Norwegian). IS-3025. Oslo, desember 2021.
   Google Scholar
• Lagerlöf I, Holte H, Glimelius I, et al. No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy. Br J Haematol. 2020;188(5):685–691. doi: 10.1111/bjh.16232.
   PubMed Web of Science ®Google Scholar
• Diehl V, Franklin J, Pfreundschuh M, et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin’s disease. N Engl J Med. 2003;348(24):2386–2395. doi: 10.1056/NEJMoa022473.
   PubMed Web of Science ®Google Scholar
• Santoro A, Magagnoli M, Spina M, et al. Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin’s lymphoma. Haematologica. 2007;92(1):35–41. doi: 10.3324/haematol.10661.
   PubMed Web of Science ®Google Scholar
• Helse Norge. Cancer patient pathways. Website: https://www.helsenorge.no/en/sykdom/kreft/cancer-patient-pathways/. Accessed June 2023.
   Google Scholar
• The Norwegian Directorate of Health. Follow-up and control of lymphomas. Cancer patient pathways for lymphomas. Website: https://www.helsedirektoratet.no/nasjonale-forlop/lymfomer/oppfolging-og-kontroll-av-lymfomer#kontroll. Accessed August, 2023.
   Google Scholar
• Lo AC, Chen B, Samuel V, et al. Late effects in survivors treated for lymphoma as adolescents and young adults: a population-based analysis. J Cancer Surviv. 2021;15(6):837–846. doi: 10.1007/s11764-020-00976-7.
   PubMed Web of Science ®Google Scholar
• Shliakhtsitsava K, Romero SAD, Dewald SR, et al. Pregnancy and child health outcomes in pediatric and young adult leukemia and lymphoma survivors: a systematic review. Leuk Lymphoma. 2018;59(2):381–397. doi: 10.1080/10428194.2017.1352097.
   PubMed Web of Science ®Google Scholar
• Smeland K, Holte H, Fagerli UM, et al. Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life. Haematologica. 2022;107(11):2698–2707. doi: 10.3324/haematol.2021.280413.
   PubMed Web of Science ®Google Scholar
• Thong MSY, van Noorden CJF, Steindorf K, et al. Cancer-related fatigue: causes and current treatment options. Curr Treat Options Oncol. 2020;21:17.
   PubMed Web of Science ®Google Scholar
• Eikeland SA, Smeland KB, Simensen VC, et al. Chronic fatigue in long-term survivors of hodgkin’s lymphoma after contemporary risk-adapted treatment. Acta Oncol. 2023;62(1):80–88. doi: 10.1080/0284186X.2023.2168215.
   PubMed Web of Science ®Google Scholar
• Daniëls LA, Oerlemans S, Krol AD, et al. Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. Br J Cancer. 2014;110(4):868–874. doi: 10.1038/bjc.2013.779.
   PubMed Web of Science ®Google Scholar
• Boelhouwer IG, Vermeer W, van Vuuren T. The associations between late effects of cancer treatment, work ability and job resources: a systematic review. Int Arch Occup Environ Health. 2021;94(2):147–189. doi: 10.1007/s00420-020-01567-w.
   PubMed Web of Science ®Google Scholar
• Jameus A, Kennedy AE, Thome C. Hematological changes following low dose radiation therapy and comparison to current standard of care cancer treatments. Dose Response. 2021;19(4):15593258211056196. doi: 10.1177/15593258211056196.
   Web of Science ®Google Scholar
• Henze L, Buhl C, Sandherr M, et al. Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the guidelines of the infectious diseases working party (AGIHO) of the german society for hematology and medical oncology (DGHO) on herpes. Ann Hematol. 2022;101(3):491–511. doi: 10.1007/s00277-021-04746-y.
   PubMed Web of Science ®Google Scholar
• Lee HS, Park JY, Shin SH, et al. Herpesviridae viral infections after chemotherapy without antiviral prophylaxis in patients with malignant lymphoma: incidence and risk factors. Am J Clin Oncol. 2012;35(2):146–150. doi: 10.1097/COC.0b013e318209aa41.
   PubMed Web of Science ®Google Scholar
• Jordan B, Margulies A, Cardoso F, et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31(10):1306–1319. doi: 10.1016/j.annonc.2020.07.003.
   PubMed Web of Science ®Google Scholar
• Gebauer J, Higham C, Langer T, et al. Long-term endocrine and metabolic consequences of cancer treatment: a systematic review. Endocr Rev. 2019;40(3):711–767. doi: 10.1210/er.2018-00092.
   PubMed Web of Science ®Google Scholar
• Chow LM, Nathan PC, Hodgson DC, et al. Survival and late effects in children with Hodgkin’s lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. J Clin Oncol. 2006;24(36):5735–5741. doi: 10.1200/JCO.2006.05.6879.
   PubMed Web of Science ®Google Scholar
• Vandraas KF, Reinertsen KV, Kiserud CE, et al. Fear of cancer recurrence among young adult cancer survivors-exploring long-term contributing factors in a large, population-based cohort. J Cancer Surviv. 2021;15(4):497–508. doi: 10.1007/s11764-020-00943-2.
   PubMed Web of Science ®Google Scholar
• Health Norway. Payment for health services. Website https://www.helsenorge.no/en/payment-for-health-services/. Accessed August 2023.
   Google Scholar
• Rostgaard K, Hjalgrim H, Madanat-Harjuoja L, et al. Survival after cancer in children, adolescents and young adults in the nordic countries from 1980 to 2013. Br J Cancer. 2019;121(12):1079–1084. doi: 10.1038/s41416-019-0632-1.
   PubMed Web of Science ®Google Scholar